esomeprazole 20 MG / naproxen 375 MG Delayed Release Oral Tablet [Vimovo]
RxNorm concept 994007, branded drug (sbd). Prescribable name: Vimovo 375 MG / 20 MG Delayed Release Oral Tablet.
- RxCUI
- 994007
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/994007 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet; Vimovo 375/20 Delayed Release Oral Tablet
Related concepts
- naproxen 375 MG (SCDC, consists of)
- esomeprazole 20 MG (SCDC, consists of)
- esomeprazole 20 MG / naproxen 375 MG [Vimovo] (SBDC, consists of)
- Delayed Release Oral Tablet (DF, has dose form)
- Vimovo (BN, has ingredient)
- esomeprazole 20 MG / naproxen 375 MG Delayed Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 75987003104
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 994007 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/994007 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 994007. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.